C57BL/6JCya-Cmc1em1/Cya
Common Name
Cmc1-KO
Product ID
S-KO-12512
Backgroud
C57BL/6JCya
Strain ID
KOCMP-67899-Cmc1-B6J-VA
When using this mouse strain in a publication, please cite “Cmc1-KO Mouse (Catalog S-KO-12512) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Cmc1-KO
Strain ID
KOCMP-67899-Cmc1-B6J-VA
Gene Name
Product ID
S-KO-12512
Gene Alias
2010110K16Rik, 2010312P05Rik
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 9
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000044220
NCBI RefSeq
NM_026442
Target Region
Exon 3
Size of Effective Region
~0.1 kb
Overview of Gene Research
Cmc1, a mitochondrial electron transport chain (ETC) complex IV chaperon protein, is crucial for the biogenesis of cytochrome c oxidase [2,4]. It functions in the mitochondrial intermembrane space and is involved in the early assembly of complex IV [2]. Its role has significant implications for mitochondrial respiration and overall cellular energy metabolism, and genetic models such as knockout mice have been used to explore its functions [1].
In T cell immunity, Cmc1 gene knockout mice studies revealed that Cmc1 is a positive regulator in CD8+ T cells activation and terminal differentiation. Genetic loss of Cmc1 inhibits the development of CD8+ T cell exhaustion in mice, and instead, deletion prompts T cells to differentiate into metabolically and functionally quiescent cells with increased memory-like features [1]. In colon adenocarcinoma, Cmc1 expression was found to be low in tissues, and functional experiments suggest it may control the proliferation ability of CRC cells [3].
In conclusion, Cmc1 plays essential roles in mitochondrial complex IV biogenesis and T cell-related immune responses. The use of Cmc1 gene knockout mouse models has provided insights into its functions in T cell-based immunotherapies and potential applications in treating colon adenocarcinoma, highlighting its significance in both basic biological processes and disease-related research [1,3].
References:
1. Chen, Yuwen, Gao, Jie, Ma, Mingyue, Cheng, Zhouli, Wu, Duojiao. 2024. The potential role of CMC1 as an immunometabolic checkpoint in T cell immunity. In Oncoimmunology, 13, 2344905. doi:10.1080/2162402X.2024.2344905. https://pubmed.ncbi.nlm.nih.gov/38659649/
2. Bourens, Myriam, Barrientos, Antoni. 2017. A CMC1-knockout reveals translation-independent control of human mitochondrial complex IV biogenesis. In EMBO reports, 18, 477-494. doi:10.15252/embr.201643103. https://pubmed.ncbi.nlm.nih.gov/28082314/
3. Xu, Zipeng, Gong, Jiantao, Hu, Weidong, Yuan, Yihang, Chen, Chaobo. 2024. The Risk Genes S1PR5, CMC1, and ASAH1 as Potential Targets for the Diagnosis, Immunotherapy, and Treatment of Colon Adenocarcinoma by Single-Cell and Bulk RNA Sequencing Analysis. In Current medicinal chemistry, , . doi:10.2174/0109298673331144241009082052. https://pubmed.ncbi.nlm.nih.gov/39513308/
4. Horn, Darryl, Zhou, Wen, Trevisson, Eva, Salviati, Leonardo, Barrientos, Antoni. 2010. The conserved mitochondrial twin Cx9C protein Cmc2 Is a Cmc1 homologue essential for cytochrome c oxidase biogenesis. In The Journal of biological chemistry, 285, 15088-15099. doi:10.1074/jbc.M110.104786. https://pubmed.ncbi.nlm.nih.gov/20220131/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
